<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01556373</url>
  </required_header>
  <id_info>
    <org_study_id>2010-A00612-37</org_study_id>
    <nct_id>NCT01556373</nct_id>
  </id_info>
  <brief_title>Effects of Acute Systemic Inflammation on Arterial Stiffness and Microcirculation.</brief_title>
  <acronym>IRIGA</acronym>
  <official_title>Effects of Acute Systemic Inflammation on Arterial Stiffness and Microcirculation.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Rennes University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Rennes University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study aims to assess the effect of acute inflammation on arterial stiffness and
      microcirculation. Patients with severe sepsis will be compared with age-, sex- and
      cardiovascular risk factors-matched controls.

      The primary outcome is the carotid-femoral pulse wave velocity. The other outcome measures
      are: systemic hemodynamics (systolic, diastolic, mean and pulse blood pressures, heart rate,
      cardiac output, left ventricular ejection fraction, systemic vascular resistances), central
      hemodynamics (aortic systolic, diastolic, mean and pulse pressures, and augmentation index),
      thenar tissue oxygen saturation, biological makers of inflammation (plasma fibrinogen,
      C-reactive protein, interleukin-6, matrix metalloproteinases -2, -9, tissue inhibitor of
      metalloproteinase 1), and plasma catecholamine concentrations (epinephrine, norepinephrine).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In a model of acute inflammation induced by salmonella typhi vaccination in healthy
      volunteers, it has been shown that acute systemic inflammation increased arterial stiffness.
      Since increased arterial stiffness (assessed by carotid-femoral pulse wave velocity) is an
      independent prognosis marker of cardiovascular risk in many chronic diseases such as
      hypertension, renal failure or diabetes mellitus, it could also be a marker of severity in
      acute inflammation states. Severe sepsis is a leading cause of hospitalisation in intensive
      care units, and constitutes a state of acute inflammation. It remains however to confirm that
      arterial stiffness is increased in this clinical conditions before evaluating its prognosis
      value.

      This study aims to assess the effect of severe sepsis on arterial stiffness and
      microcirculation. Patients with severe sepsis will be compared with age-, sex- and
      cardiovascular risk factors-matched controls.

      The primary outcome is the carotid-femoral pulse wave velocity. The other outcome measures
      are: systemic hemodynamics (systolic, diastolic, mean and pulse blood pressures, heart rate,
      cardiac output, left ventricular ejection fraction, systemic vascular resistances), central
      hemodynamics (aortic systolic, diastolic, mean and pulse pressures, and augmentation index),
      thenar tissue oxygen saturation, biological makers of inflammation (plasma fibrinogen,
      C-reactive protein, interleukin-6, matrix metalloproteinases -2, -9, tissue inhibitor of
      metalloproteinase 1), and plasma catecholamine concentrations (epinephrine, norepinephrine).
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>February 2012</start_date>
  <completion_date type="Anticipated">December 2018</completion_date>
  <primary_completion_date type="Anticipated">December 2017</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Carotid-femoral pulse wave velocity</measure>
    <time_frame>1 day</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Systemic hemodynamics</measure>
    <time_frame>1 day</time_frame>
    <description>Systolic, diastolic, mean, and pulse blood pressures, and heart rate
Cardiac output, left ventricular ejection fraction, systemic vascular resistances</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Central aortic hemodynamic</measure>
    <time_frame>1 day</time_frame>
    <description>Aortic systolic, diastolic, mean and pulse pressures,
Augmentation index</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Micro-circulation</measure>
    <time_frame>1 day</time_frame>
    <description>Thenar tissue oxygen saturation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Biological markers from plasma samples</measure>
    <time_frame>1 day</time_frame>
    <description>fibrinogen
C-reactiv protein
Interleukin-6
matrix metalloproteinases -2, -9, and tissue inhibitor of metalloproteinase 1
epinephrine and norepinephrine</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Severe Sepsis</condition>
  <arm_group>
    <arm_group_label>severe sepsis</arm_group_label>
    <description>patients with severe sepsis</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Controls</arm_group_label>
    <description>Controls matched to patients on age, sex and cardiovascular risk factors</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>NA : non interventional study</intervention_name>
    <description>NA : non interventional study</description>
    <arm_group_label>severe sepsis</arm_group_label>
    <arm_group_label>Controls</arm_group_label>
  </intervention>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      serum
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        20 patients with severe sepsis. 20 controls matched on age, sex and cardiovascular risk
        factors .
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Control group :

               -  male or female aged at least 18 years, matched on age, sex and cardiovascular
                  risk factors (smoking, hypertension, diabetes and treated dyslipidemia) with
                  septic patients

               -  Normal clinical examination and normal 12-lead ECG

               -  Routines biological tests in the normal range of the laboratories.

               -  Body mass index between 18 and 27 kg/m²

               -  Written informed consent

          -  Patients group :

               -  Male or female aged at least 18 years

               -  Severe sepsis defined by the presence of:

                    -  a systemic inflammatory response syndrome

                    -  the evidence of an infection

                    -  the presence of at least one organ failure or signs of tissue hypoperfusion.

               -  Body mass index between 18 and 27 Kg/m²

               -  Written informed consent from the patients or their relatives

        Exclusion Criteria:

          -  Control group :

               -  legal protection or persons deprived of liberty

               -  bacterial or viral infection in the month preceding inclusion

               -  current medication

               -  pregnancy or breastfeeding

               -  exclusion period stated on the national register for persons who participate to
                  biomedical research

          -  Patients group :

               -  legal protection or persons deprived of liberty

               -  vasopressor therapy

               -  bacterial or viral infection in the month preceding inclusion

               -  known cardiomyopathy

               -  pregnancy or breastfeeding
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Bruno LAVIOLLE, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Rennes University Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Eric BELLISSANT, MD, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Rennes University Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Bruno LAVIOLLE, MD, PhD</last_name>
    <phone>+33-299-2896-68</phone>
    <email>bruno.laviolle@chu-rennes.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Eric BELLISSANT, MD, PhD</last_name>
    <phone>+33-299-289-200</phone>
    <email>eric.bellissant@chu-rennes.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Service de Réanimation Chirurgicale - Hôpital de Pontchaillou</name>
      <address>
        <city>Rennes</city>
        <zip>35033</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Bruno LAVIOLLE, MD, PhD</last_name>
      <email>bruno.lavioll@chu-rennes.fr</email>
    </contact>
    <investigator>
      <last_name>Bruno LAVIOLLE, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Pascale LE MAGUET, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Unité d'Investigation Clinique - Hôpital de Pontchaillou</name>
      <address>
        <city>Rennes</city>
        <zip>35033</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Bruno LAVIOLLE, MD, PhD</last_name>
      <email>bruno.laviolle@chu-rennes.fr</email>
    </contact>
    <investigator>
      <last_name>Bruno LAVIOLLE, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>October 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 23, 2012</study_first_submitted>
  <study_first_submitted_qc>March 15, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 16, 2012</study_first_posted>
  <last_update_submitted>February 10, 2017</last_update_submitted>
  <last_update_submitted_qc>February 10, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">February 13, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>acute systemic inflammation</keyword>
  <keyword>arterial stiffness</keyword>
  <keyword>Carotid-femoral pulse wave velocity</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Inflammation</mesh_term>
    <mesh_term>Sepsis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

